Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.83
+0.31 (3.64%)
Nov 22, 2024, 4:00 PM EST - Market closed
Ocular Therapeutix Employees
Ocular Therapeutix had 267 employees as of December 31, 2023. The number of employees decreased by 7 or -2.55% compared to the previous year.
Employees
267
Change (1Y)
-7
Growth (1Y)
-2.55%
Revenue / Employee
$230,120
Profits / Employee
-$652,951
Market Cap
1.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Myriad Genetics | 2,700 |
Novavax | 1,543 |
Indivior | 1,164 |
MiMedx Group | 895 |
Arcus Biosciences | 577 |
Bicycle Therapeutics | 284 |
Syndax Pharmaceuticals | 184 |
Day One Biopharmaceuticals | 155 |
OCUL News
- 9 days ago - Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV - GlobeNewsWire
- 17 days ago - Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024 - GlobeNewsWire
- 5 weeks ago - Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix: Focus On Axpaxli's Path To Market In Wet-AMD And Implications To Investors - Seeking Alpha
- 6 weeks ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix™ to Present at October Ophthalmology Meetings - GlobeNewsWire
- 2 months ago - Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024 - GlobeNewsWire